|
Concord Biotech Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
15752.06 Cr.
|
P/BV
|
7.60
|
Book Value (Rs.)
|
198.20
|
|
52 Week High/Low (Rs.)
|
1704/987
|
FV/ML
|
1/1
|
P/E(X)
|
60.37
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
24.94
|
Div Yield (%)
|
0.50
|
|
(Rs. in Crs.)
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR |
| FaceValue | 1.00 |
| | |
| | |
| INCOME | |
| Revenue From Operations [Net] | 1046.36 |
| Other Operating Revenues | 8.53 |
| Total Operating Revenues | 1054.89 |
| | |
| Other Income | 52.36 |
| Total Revenue | 1107.25 |
| | |
| EXPENSES | |
| Cost Of Materials Consumed | 254.35 |
| Purchase Of Stock-In Trade | 62.61 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -71.28 |
| Employee Benefit Expenses | 176.90 |
| Finance Costs | 0.28 |
| Depreciation And Amortisation Expenses | 74.46 |
| Other Expenses | 264.91 |
| Total Expenses | 762.23 |
| | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 345.01 |
| | |
| Exceptional Items | -3.28 |
| Profit/Loss Before Tax | 341.74 |
| | |
| Tax Expenses-Continued Operations | |
| Current Tax | 86.29 |
| Deferred Tax | -0.87 |
| Total Tax Expenses | 85.42 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 256.32 |
| | |
| Profit/Loss From Continuing Operations | 256.32 |
| | |
| Profit/Loss For The Period | 256.32 |
| | |
| Minority Interest | 1.68 |
| Share Of Profit/Loss Of Associates | 2.91 |
| Consolidated Profit/Loss After MI And Associates | 260.91 |
| | |
| OTHER INFORMATION | |
| | |
| EARNINGS PER SHARE | |
| Basic EPS (Rs.) | 24.78 |
| Diluted EPS (Rs.) | 24.78 |
| | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |
| Equity Share Dividend | 111.94 |
